DUSP5P1 and gastric cancer: Consistently, Kaplan-Meier survival analysis demonstrated that high DUSP5P1 expression predicted shortened OS and PFS for GC patients (OS: P = 0.0005; PFS: P = 0.0017) (Fig. 1F), especially for stage I-II GC patients (OS: P = 0.0103; PFS: P = 0.0391) (Fig. 1F).